Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of fibrin glue effect on drainage after thyroidectomy
KCT0006352Phase 4Completed
- Sponsor
- GC Biopharma
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of tachosil in thyroid neoplasm and Seroma, sponsored by GC Biopharma. Primary endpoint: Postoperative drainage volume. Started Apr 2020; status: completed.
02
Drugs
tachosil
03
Conditions
thyroid neoplasmSeroma
Beyond the preview
Go deeper on KCT0006352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006352.